世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038349

体外式膜型人工肺(ECMO)の世界市場(2024-2028)

TechNavio

Global Extracorporeal Membrane Oxygenation Machines Market 2024-2028

発刊日 2024/03/08

言語英語

体裁PDF/168ページ

ライセンス/価格168ページ

0000038349

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

市場は2023年から2028年に1億4,504万米ドル、予測期間中のCAGRは5.92%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、呼吸不全や心不全の罹患率の増加、新製品の発売数の増加、臓器移植手術件数の増加によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ モダリティ別
      ◇ 静静脈および動静脈
      ◇ 静動脈
    ➣ 製品別
      ◇ ECMO装置
      ◇ ソフトウェア
    ➣ 地域別
       ◇ 北アメリカ
       ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

    本調査では、ECMO装置の技術的進歩が今後数年間の体外式膜型人工肺(ECMO)市場成長を牽引する主要因の1つであるとしています。また、ECMO装置の使用による呼吸不全患者の良好な転帰や、小児医療・治療におけるECMO装置の採用増加も、市場の大きな需要につながります。

    体外式膜型人工肺(ECMO)市場に関するレポートは、次の分野をカバーしています。

    • 体外式膜型人工肺(ECMO)市場の規模
    • 体外式膜型人工肺(ECMO)市場の予測
    • 体外式膜型人工肺(ECMO)市場の業界分析

    堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

    • 調査企業
      ➣ Abbott Laboratories
      ➣ Braile Biomedica
      ➣ Chalice Medical Ltd.
      ➣ CytoSorbents Corp.
      ➣ Edwards Lifesciences Corp.
      ➣ Eurosets Srl
      ➣ Fresenius SE and Co. KGaA
      ➣ Gen World Medical Devices
      ➣ Getinge AB
      ➣ Johnson and Johnson Services Inc.
      ➣ LivaNova PLC
      ➣ MC3 Cardiopulmonary
      ➣ Medtronic
      ➣ MicroPort Scientific Corp.
      ➣ ニプロ(Nipro Corp.)
      ➣ OriGen Biomedical Inc.
      ➣ Sechrist Industries Inc.
      ➣ Senko Medical Instrument Mfg. Co. Ltd.
      ➣ Spectrum Medical Ltd.
      ➣ テルモ(Terumo Corp.)

    また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

    この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

    このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview

2 Market Landscape
2.1 Market ecosystem

3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size
4.1 Global extracorporeal membrane oxygenation machines market 2018 - 2022
4.2 Modality Segment Analysis 2018 - 2022
4.3 Modality Segment Analysis 2018 - 2022
4.4 Product Segment Analysis 2018 - 2022
4.5 Geography Segment Analysis 2018 - 2022
4.6 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by Modality
6.1 Market segments
6.2 Comparison by Modality
6.3 Veno-venous and arterio-venous - Market size and forecast 2023-2028
6.4 Veno-arterial - Market size and forecast 2023-2028
6.5 Market opportunity by Modality

7 Market Segmentation by Product
7.1 Market segments
7.2 Comparison by Product
7.3 ECMO machines - Market size and forecast 2023-2028
7.4 Softwares - Market size and forecast 2023-2028
7.5 Market opportunity by Product

8 Customer Landscape
8.1 Customer landscape overview

9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 Canada - Market size and forecast 2023-2028
9.11 China - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Abbott Laboratories
12.4 Braile Biomedica
12.5 Chalice Medical Ltd.
12.6 Eurosets Srl
12.7 Fresenius SE and Co. KGaA
12.8 Getinge AB
12.9 LivaNova PLC
12.10 MC3 Cardiopulmonary
12.11 Medtronic
12.12 MicroPort Scientific Corp.
12.13 Nipro Corp.
12.14 OriGen Biomedical Inc.
12.15 Sechrist Industries Inc.
12.16 Senko Medical Instrument Mfg. Co. Ltd.
12.17 Terumo Corp.

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global extracorporeal membrane oxygenation machines market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits24: Five forces analysis - Comparison between 2023 and 2028
Exhibits25: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits30: Chart on Market condition - Five forces 2023 and 2028
Exhibits31: Chart on Modality - Market share 2023-2028 (%)
Exhibits32: Data Table on Modality - Market share 2023-2028 (%)
Exhibits33: Chart on Comparison by Modality
Exhibits34: Data Table on Comparison by Modality
Exhibits35: Chart on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibits36: Data Table on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
Exhibits37: Chart on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
Exhibits38: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
Exhibits39: Chart on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibits40: Data Table on Veno-arterial - Market size and forecast 2023-2028 ($ million)
Exhibits41: Chart on Veno-arterial - Year-over-year growth 2023-2028 (%)
Exhibits42: Data Table on Veno-arterial - Year-over-year growth 2023-2028 (%)
Exhibits43: Market opportunity by Modality ($ million)
Exhibits44: Data Table on Market opportunity by Modality ($ million)
Exhibits45: Chart on Product - Market share 2023-2028 (%)
Exhibits46: Data Table on Product - Market share 2023-2028 (%)
Exhibits47: Chart on Comparison by Product
Exhibits48: Data Table on Comparison by Product
Exhibits49: Chart on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on ECMO machines - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on ECMO machines - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on ECMO machines - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Softwares - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Softwares - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Softwares - Year-over-year growth 2023-2028 (%)
Exhibits57: Market opportunity by Product ($ million)
Exhibits58: Data Table on Market opportunity by Product ($ million)
Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits60: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Chart on Geographic comparison
Exhibits63: Data Table on Geographic comparison
Exhibits64: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits85: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits87: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits94: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits96: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Market opportunity By Geographical Landscape ($ million)
Exhibits101: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2023 and 2028
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories - Overview
Exhibits109: Abbott Laboratories - Business segments
Exhibits110: Abbott Laboratories - Key offerings
Exhibits111: Abbott Laboratories - Segment focus
Exhibits112: Braile Biomedica - Overview
Exhibits113: Braile Biomedica - Product / Service
Exhibits114: Braile Biomedica - Key offerings
Exhibits115: Chalice Medical Ltd. - Overview
Exhibits116: Chalice Medical Ltd. - Product / Service
Exhibits117: Chalice Medical Ltd. - Key offerings
Exhibits118: Eurosets Srl - Overview
Exhibits119: Eurosets Srl - Product / Service
Exhibits120: Eurosets Srl - Key offerings
Exhibits121: Fresenius SE and Co. KGaA - Overview
Exhibits122: Fresenius SE and Co. KGaA - Business segments
Exhibits123: Fresenius SE and Co. KGaA - Key news
Exhibits124: Fresenius SE and Co. KGaA - Key offerings
Exhibits125: Fresenius SE and Co. KGaA - Segment focus
Exhibits126: Getinge AB - Overview
Exhibits127: Getinge AB - Business segments
Exhibits128: Getinge AB - Key news
Exhibits129: Getinge AB - Key offerings
Exhibits130: Getinge AB - Segment focus
Exhibits131: LivaNova PLC - Overview
Exhibits132: LivaNova PLC - Business segments
Exhibits133: LivaNova PLC - Key news
Exhibits134: LivaNova PLC - Key offerings
Exhibits135: LivaNova PLC - Segment focus
Exhibits136: MC3 Cardiopulmonary - Overview
Exhibits137: MC3 Cardiopulmonary - Product / Service
Exhibits138: MC3 Cardiopulmonary - Key offerings
Exhibits139: Medtronic - Overview
Exhibits140: Medtronic - Business segments
Exhibits141: Medtronic - Key news
Exhibits142: Medtronic - Key offerings
Exhibits143: Medtronic - Segment focus
Exhibits144: MicroPort Scientific Corp. - Overview
Exhibits145: MicroPort Scientific Corp. - Business segments
Exhibits146: MicroPort Scientific Corp. - Key offerings
Exhibits147: MicroPort Scientific Corp. - Segment focus
Exhibits148: Nipro Corp. - Overview
Exhibits149: Nipro Corp. - Business segments
Exhibits150: Nipro Corp. - Key offerings
Exhibits151: Nipro Corp. - Segment focus
Exhibits152: OriGen Biomedical Inc. - Overview
Exhibits153: OriGen Biomedical Inc. - Product / Service
Exhibits154: OriGen Biomedical Inc. - Key offerings
Exhibits155: Sechrist Industries Inc. - Overview
Exhibits156: Sechrist Industries Inc. - Product / Service
Exhibits157: Sechrist Industries Inc. - Key offerings
Exhibits158: Senko Medical Instrument Mfg. Co. Ltd. - Overview
Exhibits159: Senko Medical Instrument Mfg. Co. Ltd. - Product / Service
Exhibits160: Senko Medical Instrument Mfg. Co. Ltd. - Key offerings
Exhibits161: Terumo Corp. - Overview
Exhibits162: Terumo Corp. - Business segments
Exhibits163: Terumo Corp. - Key news
Exhibits164: Terumo Corp. - Key offerings
Exhibits165: Terumo Corp. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations

この商品のレポートナンバー

0000038349

TOP